Computational benchmarking demonstrates superior binding affinity prediction across cold-start drug and target scenarios, highlighting improved generalizability for novel therapeutics.
Motivation Cold-start drug–target affinity prediction remains challenging because static interaction mechanisms cannot adapt to individual drug–target pairs. Results We propose PCIM-DTA, which constructs pair-level interaction representations and derives a pair-specific condition vector from global drug and target features. The condition vector modulates attention, pair-token features, distribution-aware recalibration, and regression parameters, while graph message passing captures higher-order dependencies. Experiments on Davis and BindingDB-Kd show that PCIM-DTA achieves competitive or superior performance under Warm, Cold-drug, Cold-target, Cold-both, and Scaffold-drug settings. Ablation studies support the contribution of each component. Availability and Implementation The datasets used in this study are publicly available, including the Davis and BindingDB-Kd datasets. The implementation code of PCIM-DTA is publicly available at https://github.com/1322469934/PCIM-DTA. Supplementary Information Supplementary data are available at Bioinformatics online.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: